Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Filana Therapeutics (SAVA) Q4 2025 Earnings
SAVA
12
Nov
Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.92
-0.69
-0.45
-0.22
Details
Expected EPS
-0.27
Actual EPS
-0.22
Surprise EPS
0.05
Surprise Percent
+18.52%
Description
Filana Therapeutics (SAVA) has reported earnings of -0.22 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login